{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:12:10Z","timestamp":1787667130730,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>This study aimed to investigate the mechanism of warming yang and reducing turbidity decoction in the treatment of diabetic kidney disease (DKD) by network pharmacology. The active components and corresponding targets of warming yang and reducing turbidity decoction were screened through the Traditional Chinese Medicine Systems Pharmacology database, DKD-related targets were obtained from Genecard and Online Mendelian Inheritance in Man databases, and drug-disease common targets were screened through Venny online website. Then we used STRING and Cytoscape software to analyze and perform protein\u2013protein interaction network, and used CytoNCA plug-in to perform topological analysis to screen out the core target. We used RStudio to performed gene ontology (GO) functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. One hundred one active components in warming yang and reducing turbidity decoction participated in the regulation of the body\u2019s response to foreign bodies, lipopolysaccharides, metal ions, ketone bodies, hypoxia and oxidative stress by regulating 186 targets related to DKD, and played a role in the treatment of DKD by interfering with pathways such as interfered with lipids and atherosclerosis, PI3K-Akt, fluid shear stress and atherosclerosis, AGE-RAGE and cell senescence. It was implied that warming yang and reducing turbidity decoction had the features of multi components, multi targets and multi pathways in the treatment of DKD, which might create methods and directions for further verification of the molecular mechanism of warming yang and reducing turbidity decoction.<\/jats:p>","DOI":"10.1097\/md.0000000000030728","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:24:45Z","timestamp":1664544285000},"page":"e30728","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Study on the mechanism of warming yang and reducing turbidity decoction in the treatment of diabetic kidney disease based on network pharmacology"],"prefix":"10.1097","volume":"101","author":[{"given":"Quan-Qing","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China"},{"name":"Department of Endocrinology, Gaozhou People\u2019s Hospital, Gaozhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Gaozhou People\u2019s Hospital, Gaozhou, Guangdong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-2821","authenticated-orcid":false,"given":"Ying","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Clinical practice. Nephropathy in patients with type 2 diabetes","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R4-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1755-6686.2012.00273.x","article-title":"Changing trends in end-stage renal disease due to diabetes in the United kingdom","volume":"38","author":"Hill","year":"2012","journal-title":"J Renal Care"},{"issue":"1 Suppl 1","key":"R5-20250504","first-page":"Svii, S1","article-title":"US renal data system 2014 annual data report: epidemiology of kidney disease in the united states","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11892-016-0748-0","article-title":"The role of mitochondria in diabetic kidney disease","volume":"16","author":"Hallan","year":"2016","journal-title":"Curr Diab Rep"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","article-title":"Update of pathophysiology and management of diabetic kidney disease","volume":"117","author":"Lin","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"R8-20250504","first-page":"1673","article-title":"Research progress of traditional chinese medicine in the treatment of diabetic nephropathy","volume":"23","author":"Qiu","year":"2021","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"R9-20250504","first-page":"27","article-title":"Clinical efficacy of warming yang and descending turbid traditional chinese medicine in treating diabetic nephropathy: a meta analysis","volume":"27","author":"Xiong","year":"2018","journal-title":"China Pharm"},{"key":"R10-20250504","first-page":"196","article-title":"Clinical observation on chinese medicine treatment by wenyang jiangzhuo method for diabetic nephropathy","volume":"14","author":"Xiong","year":"2012","journal-title":"J Liaoning Univ Tradi Chin Med"},{"key":"R11-20250504","first-page":"30","article-title":"Effects of warming Yang and reducing turbidity Chinese medicine on diabetic nephropathy","volume":"20","author":"Zhao","year":"2015","journal-title":"Diabetes New World"},{"key":"R12-20250504","first-page":"106","article-title":"Clinical observation on wenyang jiangzhuo decoction in treating diabetic nephropathy","volume":"16","author":"Zhao","year":"2018","journal-title":"Chin Med Mod Distance Educ China"},{"key":"R13-20250504","first-page":"121","article-title":"Clinical study on wenyang jiangzhuo traditional chinese medicine for diabetic nephropathy","volume":"6","author":"Zhang","year":"2020","journal-title":"World J Complex Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminformatics"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"300060520903642","DOI":"10.1177\/0300060520903642","article-title":"Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats","volume":"48","author":"Xiong","year":"2020","journal-title":"J Int Med Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/a-0998-7985","article-title":"Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway","volume":"129","author":"Zhang","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R17-20250504","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/323171","article-title":"Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats","volume":"2011","author":"Wang","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1080\/0886022X.2016.1227920","article-title":"Renoprotective effect of Bacopa monnieri via inhibition of advanced glycation end products and oxidative stress in STZ-nicotinamide-induced diabetic nephropathy","volume":"38","author":"Kishore","year":"2016","journal-title":"Renal Fail"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/epi-2020-0353","article-title":"Epigenetic modulation of autophagy genes linked to diabetic nephropathy by administration of isorhamnetin in Type 2 diabetes mellitus rats","volume":"13","author":"Matboli","year":"2021","journal-title":"Epigenomics"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"16r","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2010020218","article-title":"NF-kappaB in renal inflammation","volume":"21","author":"Sanz","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R23-20250504","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-017-0134-0","article-title":"Jiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K\/Akt-mediated NF-\u03baB pathways in KK-Ay mice","volume":"12","author":"Hong","year":"2017","journal-title":"Chinese Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"39349","DOI":"10.1074\/jbc.M302771200","article-title":"Phosphatidylinositol 3\u2019-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products","volume":"278","author":"Xu","year":"2003","journal-title":"J Biological Chem"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40620-020-00739-8","article-title":"Atherogenic dyslipidemia and diabetic nephropathy","volume":"33","author":"Russo","year":"2020","journal-title":"J Nephrol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ndt\/gfm631","article-title":"Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy","volume":"23","author":"Zhou","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"607924","DOI":"10.1155\/2014\/607924","article-title":"Markers of systemic inflammation and Apo-AI containing HDL subpopulations in women with and without diabetes","volume":"2014","author":"Russo","year":"2014","journal-title":"Int J Endocrinol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40618-013-0023-z","article-title":"Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease","volume":"37","author":"Russo","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10157-013-0880-y","article-title":"Abnormal lipoprotein metabolism in diabetic nephropathy","volume":"18","author":"Hirano","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","article-title":"Crosstalk between lipids and mitochondria in diabetic kidney disease","volume":"19","author":"Ducasa","year":"2019","journal-title":"Curr Diabetes Reports"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","article-title":"Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice","volume":"55","author":"Kuwabara","year":"2012","journal-title":"Diabetologia"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"F312","DOI":"10.1152\/ajprenal.00183.2020","article-title":"Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes","volume":"319","author":"Srivastava","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"F473","DOI":"10.1152\/ajprenal.00503.2013","article-title":"The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis","volume":"306","author":"Grabias","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2006.09.011","article-title":"The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications","volume":"17","author":"Navarro","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"C621","DOI":"10.1152\/ajpcell.00096.2014","article-title":"Impact of ER stress-regulated ATF4\/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-017-0127-z","article-title":"Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11684-017-0586-8","article-title":"Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells","volume":"13","author":"Fu","year":"2019","journal-title":"Front Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nm.3465","article-title":"p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice","volume":"20","author":"Bernet","year":"2014","journal-title":"Nat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:15:19Z","timestamp":1746335719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":38,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030728","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}